Ludwigshafen, Germany – July 21, 2017 – By the end of 2017, BASF will concentrate the production of XPS boards (extruded polystyrene) at its Verbund site in Ludwigshafen, Germany, which will ensure the direct supply of raw materials, optimised logistics, and direct access to research and development facilities. In view of overcapacities and low margins, the company will discontinue the production of XPS at its Schwarzheide location in Germany in the fourth quarter of this year. There will be no compulsory redundancies.
“We are implementing this measure to make sure that we remain competitive in those markets in which we are able to generate added value for our customers and for BASF in the long term”, says Klaus Ries, Head of Global Business Management Styrenic Foams at BASF. “Going forward, the full XPS product range will be available from one location, thus substantially improving our service to customers. Thanks to its state-of-the-art facilities and following numerous debottlenecking measures, Ludwigshafen offers sufficient production capacity to guarantee profitable growth.”
The welding technology developed for use on insulation boards that is currently in operation at the BASF location in Schwarzheide will be transferred to Ludwigshafen and operated from this location. This contactless, thermal welding process not only enables the manufacture of particularly thick XPS boards (BASF trade name Styrodur®), but also paves the way for a variety of interesting material combinations for the insulation material solutions of the future.
Source: BASF
The end-to-end, risk-based platform, powered by Cordant, supports regulatory reporting and operational risk management by offering real-time data and alerts for CO₂ flows across CCUS infrastructure. CarbonEdge provides an integrated dashboard that connects the entire CCUS project life cycle.
The Supervisory Board of Symrise AG has appointed Walter Ribeiro to the Executive Board with effect from September 15, 2024. Ribeiro will take over the management of the Taste, Nutrition & Health (TN&H) segment, which was previously headed by CEO Dr. Jean-Yves Parisot.
Having circled the German chemicals firm for more than a year, ADNOC in June won the target company over to disclose more data and have in-depth talks, based on an improved indicative bid of 11.7 billion euros or 62 euros per share.
